Polyps form when cells in a mucosal lining grow faster than they should and pile up into a visible bump. The causes range from inherited gene mutations that virtually guarantee polyps to everyday habits like smoking, heavy drinking, and eating a diet low in fiber. Most people think of colon polyps, but polyps also sprout in the nose, uterus, stomach, and gallbladder, each driven by a somewhat different mix of genetics, inflammation, and environmental exposure. Understanding where polyps come from matters because some types are harmless growths that never change, while others sit on a well-mapped road toward cancer.
How Normal Cells Become Polyps in the Colon
The best-studied pathway starts with a mutation in a gene called APC, a tumor suppressor that normally acts as a brake on cell growth in the colon lining. When APC stops working, cells begin dividing without the usual checks, and a small cluster of abnormal tissue forms on the intestinal wall. That cluster is an adenoma, the most common type of colon polyp. But one mutation alone is rarely enough to cause trouble. Researchers have mapped out a sequence of genetic hits, sometimes called the adenoma-carcinoma sequence, in which mutations accumulate in genes like APC, KRAS, SMAD4, and TP53. A malignant tumor typically requires alterations in at least four or five of these genes, and while the mutations often happen in a preferred order, it is the total accumulation rather than the exact sequence that determines how dangerous the growth becomes.1PubMed. Genetic alterations in the adenoma–carcinoma sequence2PubMed Central. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity
This process usually unfolds over a decade or more, which is why screening colonoscopies work so well: catching and removing a polyp at the adenoma stage interrupts the sequence before enough mutations stack up to produce cancer. In a landmark study, colonoscopic removal of adenomas reduced the expected incidence of colorectal cancer by roughly 76 to 90 percent compared to reference populations.3PubMed. Prevention of colorectal cancer by colonoscopic polypectomy
A Second Genetic Route Through Serrated Polyps
Not every colon polyp follows the classic APC-first pathway. About one in five colorectal cancers may develop through a different genetic route known as the serrated pathway. Instead of APC, the initiating event is a mutation in a gene called BRAF, which sets off a cascade of changes including widespread silencing of other genes through a chemical process called methylation. These polyps, called sessile serrated polyps, look flatter and are easier to miss during colonoscopy than the more obvious adenomas.4PubMed. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency
Research has found that almost all sessile serrated polyps carry the BRAF mutation, and when they progress to cancer, those cancers frequently lose the ability to repair errors in their DNA, a feature called mismatch repair deficiency. In one study, the mutant BRAF protein was detected in all sessile serrated polyps examined, and about four in five of the associated cancers had lost a key DNA repair protein.5Clinical Gastroenterology and Hepatology. Sessile Serrated Polyps are Precursors of Colon Carcinomas With Deficient DNA Mismatch Repair The practical takeaway is that colon polyps are not all the same biologically, and the serrated variety can be sneakier both in appearance and in the way they progress.
Inherited Syndromes That Flood the Gut with Polyps
Some people inherit mutations that make polyps almost inevitable, often in large numbers and at young ages. The most well-known is familial adenomatous polyposis, or FAP, caused by inherited mutations in the APC gene. People with FAP can develop hundreds or even thousands of adenomatous polyps throughout the colon, usually beginning in their teens. Without intervention, cancer is nearly certain by middle age. Research in Chinese families, for example, identified a specific insertion mutation in APC that tracked precisely with affected family members and was absent in unaffected relatives and controls.6PubMed. Novel insertion mutation p.Asp610GlyfsX23 in APC gene causes familial adenomatous polyposis in Chinese families
FAP is not the only inherited polyp syndrome. Juvenile polyposis syndrome, caused by mutations in BMPR1A or SMAD4, produces a distinct type of polyp called a juvenile or hamartomatous polyp, and it carries its own elevated cancer risk.7PubMed. Juvenile polyposis syndrome: An overview Peutz-Jeghers syndrome, driven by mutations in the STK11 gene, causes hamartomatous polyps mainly in the small intestine. In younger patients, the most common complication is repeated intussusception, where a segment of bowel telescopes into an adjacent segment, triggered by the polyps themselves.8PubMed Central. Peutz-Jeghers syndrome with germline mutation of STK11 These syndromes are rare, but they account for a meaningful share of polyp-related cancers in younger adults and typically require surveillance starting in childhood or early adolescence.
Processed Meat, Fiber, and What You Eat
Diet is one of the most studied lifestyle contributors to colon polyp formation. Processed meats like sausages, bacon, and deli cuts contain compounds that can damage DNA in the colon lining. When these meats are cured, they contain precursors to cancer-promoting chemicals, and cooking at high temperatures generates additional problematic compounds. A study of processed meat intake found that heavy consumers had a higher risk of colorectal adenomas, and the association appeared partly driven by specific chemicals created during high-heat cooking.9PubMed. Processed meat intake, CYP2A6 activity and risk of colorectal adenoma
The flip side of the meat story is fiber. When gut bacteria ferment dietary fiber in the colon, they produce short-chain fatty acids, the most important of which is butyrate. Butyrate is the primary fuel source for healthy colon cells and helps maintain the intestinal barrier by strengthening the mucus layer and the tight junctions between cells. Intriguingly, while butyrate promotes healthy cell growth in normal colon tissue, it has the opposite effect on cancer cells, inhibiting their proliferation.10PubMed Central. The role of butyrate in surgical and oncological outcomes in colorectal cancer Animal research has shown that the protective effects of butyrate depend on a specific transporter protein that shuttles it into colon cells, and that this protection is most clearly needed when the diet is rich in fiber.11Cancer Research. Abstract 2037: The butyrate transporter SLC5A8 is a tumor suppressor in colon linked to dietary fiber content In short, a low-fiber diet deprives colon cells of the very compound that helps keep their growth in check.
Smoking and Alcohol
Smoking is one of the strongest modifiable risk factors for colon polyps. A large study examining polyp prevalence across age groups found that current smokers had roughly two and a half to three and a half times the polyp prevalence of people who had never smoked, with the strongest effect in middle-aged adults.12PubMed Central. Colorectal Polyp Prevalence According to Alcohol Consumption, Smoking and Obesity Cigarette smoke delivers dozens of carcinogens directly into the bloodstream, where they reach the colon lining and cause the same kinds of DNA damage that drive the adenoma-carcinoma sequence.
Heavy alcohol consumption compounds the problem. Among patients who already had at least one adenoma, those who drank excessively were roughly 60 to 80 percent more likely to have large or high-risk adenomas, including those showing early signs of cancer, compared to people with irritable bowel syndrome used as a reference group.13PubMed Central. Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study Alcohol likely acts through several mechanisms: it can damage the colon lining directly, it is metabolized into acetaldehyde (a known carcinogen), and it may impair the body’s ability to absorb nutrients like folate that help maintain DNA integrity.
Obesity, Insulin Resistance, and Belly Fat
Excess body weight, and specifically the type of fat stored around the organs in the abdomen, is closely tied to adenoma risk. One study found that people in the highest category of waist-to-hip ratio were about twice as likely to have adenomas compared to those with the lowest ratio. Similarly, those with the highest insulin resistance were about 63 percent more likely to have adenomas, an association that was especially pronounced in men.14PubMed Central. Insulin Resistance, Central Obesity and Risk of Colorectal Adenomas
The link between obesity and polyps runs through insulin. When the body becomes resistant to insulin, it compensates by producing more, and those higher insulin levels boost the activity of a growth factor called IGF-1 that stimulates colon cells to multiply and discourages them from undergoing their normal programmed death.15PubMed Central. Insulin levels are associated with risk of colon adenoma and not nonadenomatous polyps: A retrospective, hospital-based study Research measuring abdominal fat directly with imaging confirmed that visceral fat area, not the fat just under the skin, correlated with adenoma risk.16Intestinal Research. Association of visceral adiposity and insulin resistance with colorectal adenoma and colorectal cancer This helps explain why two people at the same overall weight can have very different polyp risk depending on where their body stores fat.
The Gut Microbiome as a Contributing Player
The trillions of bacteria living in the colon do more than just digest fiber. Certain species appear to actively promote polyp formation. Bacteria including Fusobacterium nucleatum, specific strains of E. coli, and enterotoxigenic Bacteroides fragilis have been linked to colorectal carcinogenesis through several mechanisms: sustaining chronic low-grade inflammation, producing metabolites that damage DNA, and directly injuring the colon lining.17PubMed Central. Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis
This is not just a theoretical concern. Researchers have measured immune responses to these bacteria in people with and without polyps. Individuals whose blood showed an antibody response to a protein from F. nucleatum had nearly five times the odds of colorectal cancer, while antibody responses to proteins from another bacterium, Streptococcus gallolyticus, were associated with roughly double the odds of advanced adenomas.18PubMed Central. Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer The microbiome is likely both a cause and an amplifier: an unhealthy bacterial community fuels the conditions that let polyps form, and polyps in turn create a local environment that favors harmful bacteria. The research is still early enough that no one has a proven microbiome-based therapy for polyp prevention, but this is one of the most active areas of investigation in gastroenterology.
When Inflammation Itself Creates Polyps
People with inflammatory bowel diseases like ulcerative colitis and Crohn’s disease develop a distinctive type of polyp called a pseudopolyp. These are not driven by the genetic mutations that produce adenomas. Instead, they form when the colon wall goes through repeated cycles of ulceration and healing. The tissue that regenerates in between bouts of inflammation can overshoot, piling up into raised bumps that look like polyps on a scope but are structurally different. Pseudopolyps are generally considered non-neoplastic, meaning they are not themselves precancerous, though the chronic inflammation that causes them independently raises colorectal cancer risk.19PubMed Central. Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
Polyps Outside the Colon
The word “polyp” shows up across many organs, and the causes vary depending on location.
Nasal Polyps
Nasal polyps grow from the lining of the nasal passages and sinuses, and they are overwhelmingly driven by chronic inflammation rather than genetic mutations. The dominant mechanism in most cases is a type 2 immune response, the same branch of the immune system involved in allergies and asthma. Immune cells flood the sinus lining, producing intense swelling and tissue remodeling that eventually forms grape-like masses that obstruct breathing.20PubMed Central. Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin Nasal polyps and asthma frequently coexist because they share underlying biology: both involve eosinophilic inflammation and elevated local immune activity.21PubMed. Chronic Rhinosinusitis with Nasal Polyps and Asthma
Beyond this allergic mechanism, researchers have identified extrinsic triggers including bacterial biofilms, fungal exposure, and Staphylococcus superantigens that can provoke or worsen the immune response. The leading theory ties these triggers together: both external irritants and internal immune deficiencies can damage the epithelial barrier, the thin defensive lining of the sinuses, making deeper tissue layers vulnerable to invasion and triggering a self-perpetuating cycle of inflammation.22PubMed Central. Pathogenesis of Nasal Polyposis: Current Trends
Endometrial Polyps
Polyps inside the uterus are extremely common, and their growth is primarily influenced by hormones, specifically estrogen. One well-documented trigger is the breast cancer drug tamoxifen. Although tamoxifen blocks estrogen in breast tissue, it has the opposite effect on the uterine lining, stimulating growth. A large study found that tamoxifen users had roughly four times the risk of developing endometrial polyps compared to non-users, and the risk of endometrial hyperplasia was even higher.23JAMA Network Open. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer Outside of medication-related causes, endometrial polyps tend to become more common around menopause, when hormonal fluctuations can create an environment of unopposed estrogen stimulation.
Gallbladder Polyps
Most gallbladder polyps are cholesterol polyps, which are deposits of cholesterol rather than true tissue growths. Their formation is closely tied to how the body handles fats. A study identifying independent risk factors found that being over 50, having elevated LDL cholesterol, low HDL cholesterol, elevated liver enzymes, and a BMI above 25 all independently increased the odds.24Lipids in Health and Disease. Risk factors for cholesterol polyp formation in the gallbladder are closely related to lipid metabolism In other words, the same metabolic profile that raises your risk of heart disease also raises the risk of gallbladder polyps.
Stomach Polyps and Acid-Suppressing Medications
One of the more surprising polyp causes involves a class of medications that millions of people take daily. Long-term use of proton pump inhibitors, the drugs commonly prescribed for acid reflux, can induce a type of stomach polyp called a fundic gland polyp. These are benign and generally harmless, but they can grow large enough to be concerning on endoscopy. Case reports have documented that fundic gland polyps can regress dramatically, sometimes within five weeks, after the medication is stopped.25DEN Open. Proton pump inhibitor-induced large gastric polyps can regress within 2 months after discontinuation: Experience from two cases For people who genuinely need long-term acid suppression, the polyps are typically monitored rather than treated, but the reversibility is reassuring.
Epigenetic Changes and Aging
Even without inheriting a faulty gene, aging itself shifts the colon toward polyp-friendly territory. Over decades, chemical tags called methyl groups accumulate on the DNA of colon cells, silencing genes that should be active. When this methylation becomes widespread, it creates a pattern that researchers call the CpG island methylator phenotype, or CIMP. Tumors with this pattern show significantly more gene silencing than tumors without it.26PubMed Central. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer CIMP is particularly associated with the serrated polyp pathway discussed earlier, where BRAF mutations and gene silencing team up to push cells toward cancer. The accumulation of these epigenetic changes explains, in part, why polyp risk rises steadily with age even in people with no family history and no obvious lifestyle risk factors.
Can You Prevent Polyps from Forming?
Given all the factors that contribute to polyp growth, prevention is naturally split between things you can control and things you cannot. You cannot change your genes or stop the slow epigenetic drift of aging, but the modifiable risk factors, including diet, smoking, alcohol, weight, and physical inactivity, are substantial enough to make a real difference. The lifestyle evidence consistently points in the same direction: eat more fiber, eat less processed meat, maintain a healthy weight with attention to abdominal fat, avoid smoking, and limit alcohol.
On the pharmacological side, aspirin has attracted the most attention. A randomized trial found that taking a low daily dose of aspirin reduced the risk of any new adenoma by about 19 percent, and the risk of advanced growths by about 40 percent, compared to a placebo.27PubMed. A randomized trial of aspirin to prevent colorectal adenomas The picture is not quite as clean as it looks, though. A separate trial found that daily low-dose aspirin reduced adenoma recurrence at one year but the benefit did not hold up at the four-year mark, suggesting aspirin may slow early polyp growth more effectively than it prevents long-term recurrence.28PubMed. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial Aspirin also carries bleeding risks, so it is not recommended as a universal preventive measure for everyone. Guidelines generally reserve the recommendation for people with a higher-than-average polyp risk, after weighing the benefits against the potential harms.
The single most effective intervention remains screening. Colonoscopy does not prevent the first mutation from happening, but by finding and removing polyps before they accumulate enough genetic damage to become dangerous, it interrupts the process at its most vulnerable point. For people at average risk, screening typically begins at age 45. For those with inherited syndromes or a strong family history, surveillance starts much earlier and happens more frequently.
When Polyps Come Back After Removal
One thing that catches many people off guard is that having polyps removed does not mean you are done. The conditions that caused polyps in the first place, whether genetic predisposition, ongoing lifestyle exposure, or the slow epigenetic changes of aging, remain after the polyp is gone. Recurrence is common enough that follow-up colonoscopies are standard after any significant polyp finding. The timing of the next scope depends on what was found: a single small tubular adenoma may warrant a recheck in five to ten years, while multiple large adenomas or advanced polyps typically call for a repeat within three years. People with inherited syndromes like FAP may need annual surveillance or even prophylactic surgery to remove the colon entirely. The fact that polyps recur is not a failure of treatment; it reflects the reality that polyps are a symptom of underlying conditions, not a one-time event.